Trial of a Universal Influenza Vaccine Begins in the USA.

Universal Influenza Vaccine Phase 2 Testing Begins.                         


A Universal Influenza Vaccine

Trial of a Universal Influenza Vaccine begins in the USA.

A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and is being conducted at four U.S. sites that are part of the NIAID-funded Vaccine and Treatment Evaluation Units (VTEUs). The trial is testing an experimental vaccine called M-001 for safety and its ability to produce potentially broad protective immune responses, both on its own and when followed by a standard, licensed seasonal influenza vaccine.

Influenza viruses mutate constantly, resulting in the emergence of viruses that may not always match those targeted by seasonal and pre-pandemic influenza vaccines. Seasonal influenza vaccines are made anew each year to match the strains predicted to circulate in the upcoming season. To receive the best protection against influenza, people must be vaccinated annually. However, if a particular influenza strain changes in an unanticipated way, or a different strain from that included in the vaccine spreads widely, the seasonal influenza vaccine may not be sufficiently protective. Each year, seasonal influenza sickens millions in the United States and results in 140,000 to 710,000 hospitalizations and between 12,000 and 56,000 deaths, according to the Centers for Disease Control and Prevention.

Influenza pandemics occur when a novel influenza strain for which people have little to no protection begins to spread among humans and present a greater public health threat than seasonal influenza. For example, the 1918 influenza pandemic killed at least 50 million people worldwide. An ideal universal influenza vaccine would provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic.

"The 2017-2018 influenza season in the United States was among the worst of the last decade and serves as a reminder of the urgent need for a more effective and broadly protective influenza vaccine," said NIAID Director Anthony S. Fauci, M.D. "An effective universal influenza vaccine would lessen the public health burden of influenza, alleviate suffering and save lives. There are numerous paths of inquiry that the scientific community is pursuing, with each new study yielding more critical information and bringing us closer to our shared goal."

The new trial is being led by principal investigator Robert L. Atmar, M.D., of Baylor College of Medicine in Houston. The trial will test the M-001 vaccine candidate, developed and produced by BiondVax Pharmaceuticals based in Ness Ziona, Israel. The experimental M-001 vaccine contains antigenic peptide sequences shared among many different influenza viruses. Theoretically, it could protect against many current and emerging strains of influenza. Six previous clinical trials involving a total of 698 participants conducted by BiondVax in Israel and Europe indicated that the vaccine candidate was safe, well-tolerated and produced an immune response to a broad range of influenza strains.

The new study will enroll up to 120 healthy volunteers between the ages of 18 and 49 years. Participants will be assigned randomly to receive either two doses of the experimental vaccine or a placebo. They will be vaccinated twice, receiving one dose (1 mg; 0.4 milliliters) of M-001 or placebo via intramuscular injection on the first day and a second dose 22 days later. Approximately 172 days later, all participants will receive an approved seasonal influenza vaccine. During periodic additional clinic visits throughout the course of the study, blood will be drawn from study volunteers to evaluate their immune responses to both the experimental vaccine and to the seasonal vaccine. Each participant will be followed for approximately seven months.

The trial will take place at four NIAID-funded VTEUs. Patients will be enrolled at the Baylor College of Medicine; the University of Iowa in Iowa City; and Cincinnati Children's Hospital Medical Center. Laboratory support will be provided by Saint Louis University. For more information about the study, go to ClinicalTrials.gov, using the identifier NCT03058692.

NIAID conducts and supports research - at NIH, throughout the United States, and worldwide - to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


Posted 5/6/18

►  Here's what to do if Colds or Flu strike your household.

 

Scheduled Events

  Shadows Fall North   (5/24)
  The Cashore Marionettes   (5/25)
  Paula Poundstone   (5/25)
  Dartmouth Dance Ensemble   (5/25 & 26)
  Dartmouth Sym. Orchestra   (5/25 & 26)
  Lisbon Lilac Festival   (5/25-27)
  Casting For Kirby   (5/26)
  Memorial Day .. Comedy   (5/26)
  Music, Arts & Crafts Festival   (5/26)
  Sheep Shearing & Herding   (5/26-27)
  Weekend Craft Festival   (5/26-28)
  Lean On Pete   (5/26-30)
  The Blues Project   (5/27)
  Duck Race & Music Festival   (5/27)
  Gardens of Jackson Tour   (5/27 - 6/23)
  King of Hearts   (5/31)
  2018 Oscar Nominated Shorts   (6/1)
  FREE Fishing Day   (6/2)
  The Goyette Family   (6/2)
  Night Protocol   (6/2)
  Session Americana   (6/2)
  Wings, Water and Wheels   (6/2)
  
Celebration of Lupines  (6/2-17)
  Farewell Angelina   (6/7)
  Civil War Folk Music   (6/9)
  Iris DeMent   (6/9)
  Murder Mystery Dinner Train   (6/9)
  Farewell Angelina   (6/14)
  Girls Guns and Glory   (6/16)
  Murder Mystery Dinner Train   (6/16)
  Sweeney Todd   (6/21-7/7)
  Barbershop is Back   (6/22)
  Food Truck Festival   (6/22)
  Rhiannon Giddens   (6/22)
  'Fore the Kids' Golf Classic   (6/23)
  New England Brewfest   (6/23)
  Arts Festival   (6/23-24)
  Gail Archer, Organist   (6/24)
  Youth Ensemble   (6/28)
  SitS: Matthew Odell   (6/29)
  Asleep at the Wheel   (6/30)
  Firecracker Express   (7/4)
  The Little Red Wagon   (7/5)
  Devon Gilfillian   (7/6)
  Triathlon & Duathlon   (7/7)
  Gentri: The Gentlemen Trio   (7/13)
  SitS: Bernard Rose & Anna Lim   (7/13)
  REEL Outdoors: Mountain   (7/13)
  37th Annual Prouty   (7/13-14)
  Curtains   (7/13-15 & 19-21)
  Day Out With Thomas   (7/13-15)
  Natalie Gelman   (7/14)
  Garden Tour & Tea   (7/15)

 ◄ Expanded Calendar ►



Photo Galleries

 

Miss Berlin-Gorham Competition 2012 New England Brewfest 2014 RiverFire, Berlin, NH 2012 Sugar Hill Lupine Festival Gallery 2012 Bristol-Gorham Foliage
Quick Links

 




Business Directory

 

 

                      more ►  

 

 

Attractions

 


Area Attractions opening/closing schedules.


  Alpine Adventures
  Clark's Trading Post
  Cog Railway
  Conway Scenic Railroad
  Flume
  Fort Jefferson Fun Park
  Jericho Mountain ATV Park
  Kancamagus Highway
  Littleton Riverwalk
  Lost River Gorge
  Mountain Meadow Funplex
  Mt. Washington Auto Road
  Polar Caves
  Santa's Village
  Storyland
  Vertical Ventures
  Whale's Tail Water Park
  Woodstock Inn & Brewery

 

more ►  

 

Community Profiles

 

  Bethlehem
  Bretton Woods
  Colebrook
  Conway
  Franconia
  Gorham
  Hanover
  Jackson
  Lebanon
  Lincoln
  Littleton
  North Conway
  Pittsburg
  Plymouth
  Twin Mountain
  Whitefield
  Wolfeboro

more ►  

 

Recreation and Tourism

 

  Farm To Table Restaurants
  Hiking To Crash Sites
  Little Ski Areas
  Local Movie Theaters
  Local Performance Theaters

 

more ►  

 

Other Resources

  NH Cabins & Cottages
  NH Census Info
  NH Data (OEP)
  NH Fishing Reports
  NH Foliage Report
  NH Hiking Trail Conditions
  NH Lottery
  NH Movie Guide
  NH Road Conditions
  NH Ski Reports
  NH Snowmobile Trail Reports
  NH State Parks
  NH Town Officials Directory
  NH Weather
  White Mtn. National Forest
  VisitNH.Gov

 

 

 

Copyright 2012-2018 by George C. Jobel, 603-491-4340. All Rights Reserved.